Literature DB >> 33727920

Corrigendum to "Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis".

Bi-Cheng Wang1, Bo-Ya Xiao2, Peng-Cheng Li1, Bo-Hua Kuang1, Wang-Bing Chen1, Pin-Dong Li1, Guo-He Lin3, Quentin Liu4.   

Abstract

[This corrects the article DOI: 10.1155/2020/2368164.].
Copyright © 2021 Bi-Cheng Wang et al.

Entities:  

Year:  2021        PMID: 33727920      PMCID: PMC7935607          DOI: 10.1155/2021/3735726

Source DB:  PubMed          Journal:  J Oncol        ISSN: 1687-8450            Impact factor:   4.375


  1 in total

1.  Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.

Authors:  Bi-Cheng Wang; Bo-Ya Xiao; Peng-Cheng Li; Bo-Hua Kuang; Wang-Bing Chen; Pin-Dong Li; Guo-He Lin; Quentin Liu
Journal:  J Oncol       Date:  2020-09-29       Impact factor: 4.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.